搜尋結果
Eli Lilly climbs on win for rival weight-loss drug, and we still feel good about Abbott Labs
CNBC· 5 小時前Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable ...
(Viewpoint) Xu Zeyu: The world should know Chinese democracy as it is
The Standard· 17 小時前Is China a democracy? The question itself was the answer Mao Zedong came up with some eighty years ago, when he was challenged ...
Big Tobacco Is Now Under the Zynfluence
Bloomberg· 19 小時前The popularity of nicotine pouches has echoes of the vaping crisis. For Big Tobacco, the ideal ...
This retailer is set up for a comeback — we're getting in early by starting a position
CNBC· 1 日前Following the trade, BBY's weighting in Jim Cramer's Charitable Trust will be 1%. ...
The portfolio’s 5 best-performing stocks since the February Annual Meeting
CNBC· 1 日前The stock market has grinded its way several new all-time highs since our Annual Meeting in ...
The market is near all-time highs. That doesn't mean it can't go much higher
CNBC· 2 日前Looking at the recent performance of the market and several stocks in our portfolio, one thing ...
Council Post: From Pitch To Payout: Decoding The Investor Mindset For Startup Funding Success
Forbes· 2 日前Tech Consultant & CEO of Ingenuity Design Group, Paul Moutzouris offers product development ...
The Houston Rockets Need To Pick A Direction, And Stick To It
Forbes· 2 日前The Houston Rockets are in an awkward position. The organization showed their hand last summer, ...
SK Hynix chief says HBM chips to be double-digit percentage of 2024 DRAM chip sales
Reuters· 2 日前South Korea's SK Hynix , an Nvidia supplier, expects high-bandwidth memory (HBM) chips used ...
Discipulus Ventures mentors young founders to revive a Norman Rockwell vision of America
TechCrunch· 2 日前The program’s website is clear about this, with its call to student founders who have “a strict ...